AstraZeneca plans to directly list its shares on the NYSE while retaining its UK base and listings.
GSK CEO Emma Walmsley to step down, succeeded by chief commercial officer Luke Miels in 2026.
BP invests $5 billion in Tiber-Guadalupe offshore project in the Gulf of Mexico, targeting first production in 2030 and aiming to boost Gulf production to 400,000 boe/d by 2030.
AstraZeneca plans to directly list its shares on the NYSE while retaining its UK base and listings.
GSK CEO Emma Walmsley to step down, succeeded by chief commercial officer Luke Miels in 2026.
BP invests $5 billion in Tiber-Guadalupe offshore project in the Gulf of Mexico, targeting first production in 2030 and aiming to boost Gulf production to 400,000 boe/d by 2030.